Product
TT-01488
1 clinical trial
1 indication
Indication
B-Cell MalignanciesClinical trial
A Phase I, Multicenter, Open Label, and Dose-Escalation Study of TT-01488, Administered Orally in Adult Patients With B-Cell MalignanciesStatus: Recruiting, Estimated PCD: 2026-10-31